Business description: Constellation Pharmaceuticals, Inc.

Constellation Pharmaceuticals, Inc. discovers and develops small molecule therapeutics for the treatment of cancer, inflammatory/immunologic disorders and other diseases. The Company has three clinical-stage oncology development programs: the first program is evaluating a compound, CPI-0610, other program is evaluating a compound, CPI-1205 and CPI-0209 is initiate Phase I clinical trial and targeting solid tumors. CPI-1205 is a small molecule designed to promote anti-tumor activity by specifically inhibiting EZH2, an enzyme that suppresses target gene expression. CPI-0610 is a potent and selective small molecule designed to promote anti-tumor activity by selectively inhibiting the function of BET proteins, which are proteins that normally enhance target gene expression. The Company is conducting the ProSTAR trial, which is an open-label Phase Ib/2 clinical trial of CPI-1205 for the treatment of mCRPC in combination with enzalutamide and abiraterone acetate.

Number of employees: 154

Sales by Activity: Constellation Pharmaceuticals, Inc.

Fiscal Period: December 2019 (USD) 2020 (USD)

Geographical breakdown of sales: Constellation Pharmaceuticals, Inc.

Fiscal Period: December 2019 (USD) 2020 (USD)

Executive Committee: Constellation Pharmaceuticals, Inc.

Manager TitleAgeSince
President - -
Investor Relations Contact - -
Corporate Officer/Principal - 31/07/2016
Chief Operating Officer 62 31/03/2017

Composition of the Board of Directors: Constellation Pharmaceuticals, Inc.

Director TitleAgeSince
Director/Board Member - 14/07/2021
Director/Board Member - -

Company details: Constellation Pharmaceuticals, Inc.

Constellation Pharmaceuticals, Inc.

215 First Street

02142, Cambridge

+

http://constellationpharma.com
address Constellation Pharmaceuticals, Inc.(CNST)

Bio Therapeutic Drugs

Change 5-day change 1-year change 3-year change Capi.($)
+2.35%+2.74%+38.10%+74.02% 56.54B
-1.93%-6.51%+25.66%+62.29% 53.6B
-2.44%+1.40%-15.61%-13.72% 22.91B
-2.85%-7.78%-9.28%+352.92% 21.37B
+0.15%+0.36%+24.28%-14.44% 20.27B
+0.30%-2.28%+31.86%-29.13% 17.56B
-1.45%-7.15%+17.96%+554.50% 14.75B
+3.41%-6.61%+162.81%+287.77% 13.53B
-5.25%-4.23%+42.32%+160.72% 13.33B
Average -0.14%-3.79%+35.34%+159.44% 25.98B
Weighted average by Cap. +0.02%-2.96%+30.18%+120.42%
  1. Stock Market
  2. Stocks
  3. CNST Stock
  4. Company Constellation Pharmaceuticals, Inc.